nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Actinomycin D and staurosporine, potent apoptosis inducers in vitro, are potentially effective chemotherapeutic agents against glioblastoma multiforme
|
Narita, Yoshitaka |
|
2000 |
45 |
2 |
p. 149-156 |
artikel |
2 |
Altered response to thyroid hormones by prostate and breast cancer cells
|
Martinez, M. B. |
|
2000 |
45 |
2 |
p. 93-102 |
artikel |
3 |
Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer
|
Gallo, Daniela |
|
2000 |
45 |
2 |
p. 127-132 |
artikel |
4 |
Different microtubule network alterations induced by pachymatismin, a new marine glycoprotein, on two prostatic cell lines
|
Sangrajrang, Suleeporn |
|
2000 |
45 |
2 |
p. 120-126 |
artikel |
5 |
Estrogen agonistic/antagonistic effects of miproxifene phosphate (TAT-59)
|
Shibata, Jiro |
|
2000 |
45 |
2 |
p. 133-141 |
artikel |
6 |
Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen
|
Braybrooke, Jeremy P. |
|
2000 |
45 |
2 |
p. 111-119 |
artikel |
7 |
Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study
|
Merimsky, Ofer |
|
2000 |
45 |
2 |
p. 177-181 |
artikel |
8 |
Impact of the simultaneous administration of the (+)- and (−)-forms of formyl-tetrahydrofolic acid on plasma and intracellular pharmacokinetics of (−)-tetrahydrofolic acid
|
Schleyer, Eberhard |
|
2000 |
45 |
2 |
p. 165-171 |
artikel |
9 |
In vitro antioxidant properties of amifostine (WR-2721, Ethyol)
|
Marzatico, Fulvio |
|
2000 |
45 |
2 |
p. 172-176 |
artikel |
10 |
Modulation of RTX cytotoxicity by thymidine and dipyridamole in vitro: implications for chemotherapy
|
Lehman, N. L. |
|
2000 |
45 |
2 |
p. 142-148 |
artikel |
11 |
Pharmacokinetics of oxaliplatin in patients with normal versus impaired renal function
|
Massari, Claire |
|
2000 |
45 |
2 |
p. 157-164 |
artikel |
12 |
Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation
|
Roberts, John D. |
|
2000 |
45 |
2 |
p. 103-110 |
artikel |